Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

LSCC SNP variant regulates SOX2 modulation of VDAC3.

Chyr J, Guo D, Zhou X.

Oncotarget. 2018 Apr 27;9(32):22340-22352. doi: 10.18632/oncotarget.24918. eCollection 2018 Apr 27.

2.

Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.

Cui Y, Cui CA, Yang ZT, Ni WD, Jin Y, Xuan YH.

Exp Mol Pathol. 2017 Apr;102(2):347-353. doi: 10.1016/j.yexmp.2017.03.004. Epub 2017 Mar 9.

PMID:
28286162
3.

SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma.

Tang XB, Shen XH, Li L, Zhang YF, Chen GQ.

Auris Nasus Larynx. 2013 Oct;40(5):481-6. doi: 10.1016/j.anl.2013.01.003. Epub 2013 Feb 23.

PMID:
23462687
4.

The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.

Karachaliou N, Rosell R, Viteri S.

Transl Lung Cancer Res. 2013 Jun;2(3):172-9. doi: 10.3978/j.issn.2218-6751.2013.01.01. Review.

5.

SOX2 and cancer: current research and its implications in the clinic.

Weina K, Utikal J.

Clin Transl Med. 2014 Jul 4;3:19. doi: 10.1186/2001-1326-3-19. eCollection 2014. Review.

6.

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.

Vencken SF, Sethupathy P, Blackshields G, Spillane C, Elbaruni S, Sheils O, Gallagher MF, O'Leary JJ.

BMC Genomics. 2014 Aug 25;15:711. doi: 10.1186/1471-2164-15-711.

7.

SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.

Yang N, Hui L, Wang Y, Yang H, Jiang X.

Oncol Rep. 2014 Jun;31(6):2651-9. doi: 10.3892/or.2014.3120. Epub 2014 Apr 2.

PMID:
24700142
8.

Endometrial vezatin and its association with endometriosis risk.

Holdsworth-Carson SJ, Fung JN, Luong HT, Sapkota Y, Bowdler LM, Wallace L, Teh WT, Powell JE, Girling JE, Healey M, Montgomery GW, Rogers PA.

Hum Reprod. 2016 May;31(5):999-1013. doi: 10.1093/humrep/dew047. Epub 2016 Mar 22.

PMID:
27005890
9.

Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.

Eini R, Stoop H, Gillis AJ, Biermann K, Dorssers LC, Looijenga LH.

PLoS One. 2014 Jan 3;9(1):e83585. doi: 10.1371/journal.pone.0083585. eCollection 2014.

10.

Higher-order chromatin domains link eQTLs with the expression of far-away genes.

Duggal G, Wang H, Kingsford C.

Nucleic Acids Res. 2014 Jan;42(1):87-96. doi: 10.1093/nar/gkt857. Epub 2013 Oct 1.

11.

SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.

Watanabe H, Ma Q, Peng S, Adelmant G, Swain D, Song W, Fox C, Francis JM, Pedamallu CS, DeLuca DS, Brooks AN, Wang S, Que J, Rustgi AK, Wong KK, Ligon KL, Liu XS, Marto JA, Meyerson M, Bass AJ.

J Clin Invest. 2014 Apr;124(4):1636-45. doi: 10.1172/JCI71545. Epub 2014 Mar 3.

12.

Evaluation of Sox2 binding affinities for distinct DNA patterns using steered molecular dynamics simulation.

Yesudhas D, Anwar MA, Panneerselvam S, Kim HK, Choi S.

FEBS Open Bio. 2017 Oct 9;7(11):1750-1767. doi: 10.1002/2211-5463.12316. eCollection 2017 Nov.

13.

SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.

Ferone G, Song JY, Sutherland KD, Bhaskaran R, Monkhorst K, Lambooij JP, Proost N, Gargiulo G, Berns A.

Cancer Cell. 2016 Oct 10;30(4):519-532. doi: 10.1016/j.ccell.2016.09.001.

14.

Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.

Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, Chuu CP, Chen CY, Hsiung CA, Chang JY, Wang LH, Chang IS, Jiang SS.

Int J Cancer. 2014 Aug 15;135(4):809-19. doi: 10.1002/ijc.28734. Epub 2014 Jan 30.

15.

SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell.

Jia X, Li X, Xu Y, Zhang S, Mou W, Liu Y, Liu Y, Lv D, Liu CH, Tan X, Xiang R, Li N.

J Mol Cell Biol. 2011 Aug;3(4):230-8. doi: 10.1093/jmcb/mjr002. Epub 2011 Mar 17.

PMID:
21415100
16.

Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.

Samulin Erdem J, Skaug V, Bakke P, Gulsvik A, Haugen A, Zienolddiny S.

BMC Cancer. 2016 Jan 19;16:28. doi: 10.1186/s12885-016-2061-3.

17.

SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells.

Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D, Li N.

PLoS One. 2012;7(5):e36326. doi: 10.1371/journal.pone.0036326. Epub 2012 May 15.

18.

Expression Quantitative Trait Loci Information Improves Predictive Modeling of Disease Relevance of Non-Coding Genetic Variation.

Croteau-Chonka DC, Rogers AJ, Raj T, McGeachie MJ, Qiu W, Ziniti JP, Stubbs BJ, Liang L, Martinez FD, Strunk RC, Lemanske RF Jr, Liu AH, Stranger BE, Carey VJ, Raby BA.

PLoS One. 2015 Oct 16;10(10):e0140758. doi: 10.1371/journal.pone.0140758. eCollection 2015. Review.

19.
20.

Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs.

Brown CD, Mangravite LM, Engelhardt BE.

PLoS Genet. 2013;9(8):e1003649. doi: 10.1371/journal.pgen.1003649. Epub 2013 Aug 1.

Supplemental Content

Support Center